Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baihua Dingchuan Wan is a traditional Chinese medicine (TCM) manufactured by Liaoning Jindan Pharmaceutical. It is an approved pharmaceutical product in China, primarily indicated for the treatment of cough and bronchial asthma characterized by the 'phlegm-heat obstructing the lungs' pattern in TCM theory. The formulation is designed to clear heat, transform phlegm, and suppress cough and wheezing. It contains a blend of herbal and mineral ingredients, including Ephedra, Bitter Apricot Seed, and Scutellaria, which provide bronchodilatory and anti-inflammatory effects. The product is typically administered orally in the form of water-honeyed pills.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on baihua dingchuan wan.